• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMU
Click for more information
4.26% 4.5¢

IMUGENE LIMITED - Charts / Financials

Market Cap $386.7M  ! watchlist Created with Sketch. Add to my watchlist

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.59pm 06/11/2024 (20 minute delay) ?
Day
Open 4.7¢   Day High 4.8¢   Day Low 4.4¢
Daily Volume 19428279
Bids   Sellers
Number Price Volume   Number Price Volume
2 4.5¢ 176601   8 4.6¢ 969572

Directors & Senior Management

Mr. Paul E. Hopper Executive Chairman of the Board
Ms. Leslie Chong Chief Executive Officer, Managing Director, Executive Director
Mr. Michael Tonroe Chief Financial Officer, Company Secretary
Dr. Bradley Glover Chief Operating Officer
Dr. Nicholas Ede Chief Technology Officer
Dr. Monil Shah Chief Business Officer
Dr. Paul Woodard Chief Medical Officer
Ms. Kimberlee Cobleigh Drapkin Non-Executive Independent Director
Dr. Jakob Dupont Non-Executive Independent Director
Dr. Jens W. Eckstein Non-Executive Independent Director
Dr. Lesley Russell Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
4.5¢ 		Change
-0.002(4.26%) 		Mkt cap ! $386.7M
Open High Low Value Volume
4.7¢ 4.8¢ 4.4¢ $890.8K 19.42M

Buyers (Bids)

No. Vol. Price($)
2 176601 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 969572 8
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
Last
4.5¢ 		  Change
-0.002 ( 2.81 %)
Open High Low Volume
4.8¢ 4.8¢ 4.5¢ 9435451
Last updated 15.59pm 06/11/2024 ?

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

On October 24, the USA reportedly approached its G7 counterparts and proposed a ban on Russian titanium, and, palladium.
Bitcoin jumps 8% to beat record on Trump vote optimism Bitcoin has been a big winner on financial markets today, tracking Donald Trump's election highs with an 8% rise and beating a previous record
Nanocap Si6 Metals to kick off drilling at Monument gold project WA, chasing past hits Nanocap Si6 Metals (ASX:SI6) is on the cusp of kicking off drilling at its Monument project in WA, sniffing after historical gold hit targets.
The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint Let’s get straight to the point: of all the smallcaps in the Telecommunications index, The Market Ltd could be one of the most overlooked.
Lord picks up high-grade copper play in Western Australia, with past intercepts of up to 6.62% Lor Resources Ltd has entered into a binding earn-in agreement with Blackrock Resources Pty Ltd to take on up to 80% of the Ilgarari project
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.